Drug Shortage Report for ZARONTIN
| Report ID | 121985 |
| Drug Identification Number | 00022799 |
| Brand name | ZARONTIN CAP 250MG |
| Common or Proper name | ZARONTIN CAPSULES |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHOSUXIMIDE |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 TABS |
| ATC code | N03AD |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-08-03 |
| Actual start date | 2020-08-04 |
| Estimated end date | 2020-09-22 |
| Actual end date | 2020-09-24 |
| Shortage status | Resolved |
| Updated date | 2020-09-25 |
| Company comments | ZARONTIN SYRUP AVAILABLE |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-09-25 | French | Compare |
| v7 | 2020-09-25 | English | Compare |
| v6 | 2020-09-17 | French | Compare |
| v5 | 2020-09-17 | English | Compare |
| v4 | 2020-09-09 | French | Compare |
| v3 | 2020-09-09 | English | Compare |
| v2 | 2020-08-10 | French | Compare |
| v1 | 2020-08-10 | English | Compare |
Showing 1 to 8 of 8